Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 25.49.
Forward PE Ratio (25.49) = Close Price ($280.76) / Consensus Forward EPS ($11.32)
FORWARD PE RATIO
25.49
SECTOR MEDIAN · HEALTHCARE
20.01
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
+27.39%
vs the sector median at left
Charles River Laboratories International, Inc.
Market Cap
$13.52B
Forward PE Ratio
25.49
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Charles River Laboratories International, Inc. (CRL) | $13.52B | 25.49 |
| The Cooper Companies, Inc. (COO)vs › | $13.20B | 15.03 |
| Revvity, Inc. (RVTY)vs › | $14.18B | 24.31 |
| Baxter International Inc. (BAX)vs › | $12.85B | 12.58 |
| Penumbra, Inc. (PEN)vs › | $12.58B | 68.43 |
| Exelixis, Inc. (EXEL)vs › | $14.50B | 19.80 |
| Encompass Health Corporation (EHC)vs › | $11.95B | 19.92 |
| DaVita Inc. (DVA)vs › | $11.56B | 12.39 |
| Solventum Corporation (SOLV)vs › | $15.60B | 12.81 |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 37.66 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
25.5
consensus next-FY EPS
At today's $280.76 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-27 | $11.32 | $11.11 – $11.45 | 9 | 24.8x |
| 2027-12-27 | $12.73 | $12.03 – $13.14 | 10 | 22.0x |
| 2028-12-27 | $14.15 | $8.82 – $17.85 | 5 | 19.8x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
